Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $162.3800 (0.48%) ($160.8100 - $163.0200) on Tue. Jan. 3, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.12% (three month average) | RSI | 34 | Latest Price | $162.3800(0.48%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV declines -0.1% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XBI(9%) MCHI(8%) FXI(7%) SHY(7%) EEM(6%) | Factors Impacting ABBV price | ABBV will decline at least -0.56% in a week (0% probabilities). VIXM(-9%) IWN(-9%) JETS(-8%) IWM(-8%) IWC(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.56% (StdDev 1.12%) | Hourly BBV | 0 () | Intraday Trend | 0.2% | | | |
|
Resistance Level | $162.63 | 5 Day Moving Average | $162.33(0.03%) | 10 Day Moving Average | $162.44(-0.04%) | 20 Day Moving Average | $162.63(-0.15%) | To recent high | -2.2% | To recent low | 17.4% | Market Cap | $286.484b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |